ARMS2 and age-related macular degeneration: Several studies have considered the role of genetic variants during the development and progression of AMD, such as complement factor H gene (CHF), age-related maculopathy susceptibility gene2 (ARMS2), and tissue inhibitor of metalloproteinase 3 (TIMP3) [14].